Detailed Instructions: Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.
Q: Paragraph: The article does not mention the cost of hormone therapy or compare its cost against that of other therapies. Since the story suggests that treatment might be helpful in younger women with severe hot flashes, cost is relevant. The article suggests that hormone therapy might help younger women control hot flashes. But the primary subject of both the Newsweek story and the new research is harms of therapy, not benefits, so we consider this criterion not applicable in this case. The Newsweek story summarizes the previously published analyses of the Women's Health Initiative trials, which found that women who received hormone therapy had a slightly higher risk of heart attacks, strokes, blood clots, and breast cancer than women who received placebo. It reports new data on the harms of hormone therapy in women who have hot flashes and night sweats. However, the story does not report the frequency of these potential harms, making it difficult for readers to judge their risks. Some readers with bad hot flashes and night sweats might think the risks of heart attack and death are too small to worry about, others might not. (See "Comments" below.) The article fails to alert the reader to the provisional quality of the new findings. As the researchers note in their published manuscript, the current subgroup and secondary analyses are "exploratory" and "not statistically significant." In other words, they represent very interesting hypotheses for further exploration. The also demonstrate how little we know about menopausal symptoms and their management. The news story says only that the analyses "had some technical issues." According to the story, hot flashes might be "dangerous" because they might predict heart disease. Thus, the article adds another normal feature of aging (postmenopausal hot flashes) to the list of experiences that are not only distressing and uncomfortable but also apparently perilous to a woman's health. Unfortunately, the article fails to note that none of the research findings are statistically significant. Hot flashes might be important, or they might not. The article cites the lead author of the new study, who is also the head of the Women's Health Initiative. But a second source not associated with the research might have added a valuable and different perspective, perhaps pointing out that the evidence is weak and does not warrant action by women or their health care providers. The story mentions one option to hormone therapy for managing difficult symptoms of menopausedoing nothing. The current evidence suggests there are few other good options. But there are several strategies for preventing and treating heart disease and stroke, including exercise and diet, as well as monitoring risk factors such as high blood pressure and cholesterol. The story does not mention availability, but most readers affected by hot flashes will be familiar with hormone therapy. The article accurately suggests that hormone therapy is not a new treatment. The story did not appear to rely solely or largely on a news release. Claim: Menopause: A flash of concern
A:
0